As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education and atypical infections.
|Articles|August 26, 2015
Kimberly Jewett Discusses Pathology as Part of the Treatment Process
Author(s)Kimberly Jewett
Kimberly Jewett discusses how retrieving her pathology report delayed the treatment process. Jewett says pathologists should come out from behind the microscope and engage with patients.
Advertisement
Kimberly Jewett, a two-time breast cancer survivor, president and CEO, Kimberly Jewett Consulting, Inc., discusses how retrieving her pathology report delayed the treatment process. Jewett says pathologists should come out from behind the microscope and engage with patients.
Advertisement
Related to this article
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Ellery Palanuk, MSN, RN, CN-BN, explains how navigators rely on multidisciplinary teams and tumor boards as breast cancer treatment evolves.
At EONS 2026, a City of Hope nurse practitioner explains how shifting immunotherapy from infusion to injection can free nurse and chair time.
Oncology nurses play a key role guiding patients about AI breast cancer risk assessment tools, dynamic re-testing, and individualized screening plans.
Dana-Farber nurse practitioners outline ADC patient selection, sequencing, ILD surveillance, and patient education from JADPRO Live 2026.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses
2
What Nurses Should Tell Patients About Vitamin C in CCUS and MDS
3
Education, Infection Vigilance Define Outpatient Bispecific Care
4
ESMO 2026 Poll: Which New Data Will Change Your Practice First?
5